Tina Ventura
Chief Investor Relations Officer
Replay available
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q4 2025 earnings conference call, held 2026-02-19. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Sibbles
Chief Executive Officer
Dave Sorgel
Chief Medical Officer
Marty Deer
Chief Financial Officer
Ellie Merle
Analyst, Barclays
Thomas Smith
Analyst, Learing Partners
Prakhar Agrawal
Analyst, Cantor Fitzgerald
Michael DeFore
Analyst, Evercore
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.694 Good morning and thank you for standing by. 00:00:02.694 -- 00:00:07.820 Welcome to McGregor Pharmaceuticals' fourth quarter and full year 2025 earnings 00:00:07.820 -- 00:00:13.807 conference call. At this time, all participants are in a listen-only mode. 00:00:13.807 -- 00:00:18.693 After the speaker's presentation, there will be a question and answer session. 00:00:18.693 -- 00:00:22.297 As a reminder, today's conference call is being recorded. 00:00:22.297 -- 00:00:27.924 I would now like to introduce Ms. Tina Ventura, Chief Investor Relations 00:00:27.924 -- 00:00:31.305 Officer. Please go ahead. 00:00:31.452 -- 00:00:35.638 Thank you, Michelle. Good morning, everyone, and thank you for joining us to discuss 00:00:35.638 -- 00:00:39.584 Madrigal's fourth quarter and full year 2025 earnings. 00:00:39.584 -- 00:00:44.412 We issued a press release this morning and posted a slide deck to accompany this webcast 00:00:44.412 -- 00:00:48.054 on the investor relations section of our website. 00:00:48.057 -- 00:00:52.624 On the call with me today is Bill Sibbles, Chief Executive Officer, Dave Sorgel, Chief 00:00:52.624 -- 00:00:56.310 Medical Officer, and Marty Deer, Chief Financial Officer. 00:00:56.310 -- 00:01:00.241 They will provide prepared remarks followed by Q&A. 00:01:00.241 -- 00:01:04.806 Please note on slide two, we will be making certain forward-looking statements today. 00:01:04.806 -- 00:01:10.694 We refer you to our SEC filings for a discussion of the risks that may cause actual results 00:01:10.694 -- 00:01:12.996 to differ from the forward-looking statements. 00:01:12.996 -- 00:01:16.340 With that, I will now turn the call over to Bill on slide three. 00:01:16.340 -- 00:01:19.144 Thanks, Tina. Good morning and thanks ...